Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.2.1.13 (
glyceraldehyde-3-phosphate dehydrogenase
)
6,511
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The structural gene (gap) encoding
glyceraldehyde-3-phosphate dehydrogenase
(
GAPDH
; EC 1.2.1.12) from Streptomyces aureofaciens (Sa) has been cloned and sequenced. The predicted gap product consists of 332 amino acids (aa) (35,312 Da), and has considerable homology (up to 52% aa identity) with other bacterial and eukaryotic gap genes. Sequence analysis of the regions flanking gap revealed two incomplete open reading frames encoding proteins similar to the
AraC
family of bacterial transcriptional regulators and delta (5)-3-ketosteroid isomerase. The Sa gap gene was expressed at a high level in Escherichia coli (Ec). Transformation of the Ec strain resulted in an up to eightfold increase in specific
GAPDH
activity.
...
PMID:Cloning, sequencing and expression in Escherichia coli of a Streptomyces aureofaciens gene encoding glyceraldehyde-3-phosphate dehydrogenase. 748 20
We have previously shown that cytosine arabinoside (
AraC
)-induced apoptosis of cerebellar granule cells (CGCs) results in an increase of a 38-kDa band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, identified as
glyceraldehyde-3-phosphate dehydrogenase
(
GAPDH
; EC 1.2.1.12). Antisense oligonucleotides to GAPDH mRNA afford acutely plated CGCs significant protection against
AraC
-induced apoptosis. We used differential centrifugation to examine which subcellular components are affected. Treated and untreated cells were sonicated in 0.32 M sucrose and sequentially centrifuged at 1,000, 20,000, and 200,000 g, to obtain crude nuclear, mitochondrial, microsomal, and cytosolic fractions. Western blotting showed that the levels of
GAPDH
protein were markedly increased in the 1,000- and 20,000-g pellets. The levels in the cytosolic supernatant were decreased dramatically by
AraC
in acutely plated CGCs but not in cells 24 h after plating. It is noteworthy that although
GAPDH
protein in the pellet fractions increased, the dehydrogenase activity of
GAPDH
decreased. Two other dehydrogenases, lactate dehydrogenase (EC 1.1.1.27) and glucose-6-phosphate dehydrogenase (EC 1.1.1.49), were not similarly affected, suggesting that the effect was
GAPDH
specific. These observations suggest that
GAPDH
levels change in specific organelles during apoptosis for reasons that are separate from its function as a glycolytic enzyme. The accumulation of
GAPDH
protein in specific subcellular loci may play a role in neuronal apoptosis.
...
PMID:Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. 934 24
Treatment with cytosine beta-D-arabinoside (
AraC
; 300 microM) induced a time-dependent accumulation of
glyceraldehyde-3-phosphate dehydrogenase
(
GAPDH
) protein in nuclei purified from cultured cerebellar granule cells, with a concomitant degradation of lamin B1, a nuclear membrane protein and a substrate of CPP32/caspase-3. Moreover, Asp-Glu-Val-Asp-fluoromethyl ketone (DEVD-fmk), a CPP32-selective antagonist, dose-dependently suppressed
AraC
-induced apoptosis of these neurons. Nuclear accumulation of
GAPDH
protein was associated with a progressive decrease in the activity of uracil-DNA glycosylase (UDG), one of the nuclear functions of
GAPDH
. The nuclear dehydrogenase activity of
GAPDH
was initially increased after treatment and then decreased parallel to UDG activity. Six
GAPDH
isoforms were detected in the nuclei of
AraC
-treated cells. The more alkaline isoforms, 1-3, constituted the bulk of the nuclear
GAPDH
, and the remaining isoforms, 4-6, were the minor species. Levels of all six isoforms were increased after treatment with
AraC
for 16 h; a 4-h treatment increased levels of only isoforms 4 and 5. Thus, it appears that various
GAPDH
isoforms are differentially regulated and may have distinct apoptotic roles. Pretreatment with
GAPDH
antisense oligonucleotide blocked the nuclear translocation of
GAPDH
isoforms, and the latter process occurred concurrently with a decrease in cytosolic
GAPDH
isoforms. Sodium nitroprusside-induced NAD labeling of nuclear
GAPDH
showed a 60% loss of
GAPDH
labeling after
AraC
treatment, suggesting that the active site of
GAPDH
may be covalently modified, denatured, or improperly folded. The unfolded protein response elicited by denatured
GAPDH
may contribute to
AraC
-induced neuronal death.
...
PMID:Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. 1003 63
We recently reported that cytosine arabinoside (
AraC
)-induced apoptosis of cerebellar neurons involves the overexpression of
glyceraldehyde-3-phosphate dehydrogenase
(
GAPDH
). The present study was undertaken to investigate whether p53 and/or Bax overexpression participates in the
AraC
-induced apoptosis of cerebellar granule cells and, if so, the relationship between p53 induction and
GAPDH
overexpression in these cells.
AraC
-induced apoptosis of cerebellar granule cells was preceded by an increase in levels of p53 mRNA and protein detected between 1 and 8 hr after treatment. The mRNA level for a p53 target gene, Bax, was also increased. The increase in GAPDH mRNA lasted longer than that of either p53 or Bax, and the level of
GAPDH
protein in the particulate fraction increased after induction of GAPDH mRNA. The antisense oligonucleotide to p53 protected granule cells from
AraC
-induced chromatin condensation, internucleosomal cleavage, and apoptotic death. The inhibition of p53 expression by the p53 antisense oligonucleotide not only blocked the expression of Bax but also partially suppressed the increased GAPDH mRNA and protein levels. Conversely, the suppression of
GAPDH
expression and subsequent attenuation of apoptosis of granule cells by
GAPDH
antisense oligonucleotide did not influence the expression of p53 or Bax. Cerebellar granule cells prepared from p53 knock-out mice were resistant to
AraC
toxicity, and the p53 gene knock-out suppressed
AraC
-upregulated
GAPDH
expression. Moreover, infection of PC12 cells with an adenoviral vector containing p53 gene dramatically increased
GAPDH
expression and triggered cell apoptosis. These results suggest that
AraC
-induced apoptosis of cerebellar granule cells involves the expression of both
GAPDH
and p53 and that, similar to Bax,
GAPDH
is upregulated by p53 after exposure to the apoptotic insult.
...
PMID:Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53. 1053 67
Expression of the gap gene encoding
glyceraldehyde-3-phosphate dehydrogenase
(
GAPDH
) is developmentally regulated, and induced by glucose in Streptomyces aureofaciens. A gene, gapR, encoding a protein similar to the
AraC
/XylS family of bacterial transcriptional regulators was identified upstream of gap. The gapR gene was constitutively expressed from a single promoter during the course of differentiation. By integrative transformation, via double crossover, a stable null mutant of the gapR gene was obtained. The mutation only slightly affected growth, and had no effect on differentiation of S. aureofaciens. However, transcription of the
GAPDH
-encoding gap gene was substantially reduced in the S. aureofaciens DeltagapR null mutant, irrespective of carbon source used. Though
GAPDH
activity was about 1.5-fold lower in the mutant, the substantial enzyme activity remained, suggesting the presence of a second
GAPDH
which is sufficient to ensure growth. The GapR protein, overproduced in Escherichia coli, was shown to bind upstream of the gap-P promoter region. The results indicate a direct role of GapR in regulation of gap expression in S. aureofaciens.
...
PMID:Expression of the gap gene encoding glyceraldehyde-3-phosphate dehydrogenase of Streptomyces aureofaciens requires GapR, a member of the AraC/XylS family of transcriptional activators. 1132 Jan 32
A gapR gene, encoding a protein similar to the
AraC
/XylS family of bacterial transcriptional regulators, was previously identified upstream of the gap gene, coding for
glyceraldehyde-3-phosphate dehydrogenase
in Streptomyces aureofaciens. The GapR protein overproduced in Escherichia coli was shown to bind to the gap-P promoter region. Using the gel mobility shift assay with cell-free protein extracts from different developmental stages of S. aureofaciens, we identified several other proteins, in addition to GapR, that specifically bound to the S. aureofaciens gap-P promoter region. When cell-free extracts from S. aureofaciens cultivated in liquid medium with glucose were analyzed, only one complex corresponding to GapR was detected. A new protein interacting with the gap-P promoter was detected in stationary culture of S. aureofaciens grown in the presence of mannitol as carbon sources. The GapR protein was partially purified from S. aureofaciens cultivated in liquid medium containing glucose and used for binding studies. DNA footprinting analysis revealed an identical protected region as previously identified for the GapR protein overproduced from Escherichia coli. The direct role of the GapR protein in the regulation of gap expression in S. aureofaciens in vivo was confirmed but regulation of gap expression seems to be more complex, possibly involving other regulatory protein(s), depending on the developmental stage of S. aureofaciens.
...
PMID:Some features of DNA-binding proteins involved in the regulation of the Streptomyces aureofaciens gap gene, encoding glyceraldehyde-3-phosphate dehydrogenase. 1242 8